Minglu Liang

1.2k total citations
52 papers, 884 citations indexed

About

Minglu Liang is a scholar working on Molecular Biology, Cancer Research and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Minglu Liang has authored 52 papers receiving a total of 884 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 13 papers in Cancer Research and 9 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Minglu Liang's work include Adipose Tissue and Metabolism (7 papers), Natural product bioactivities and synthesis (5 papers) and Angiogenesis and VEGF in Cancer (5 papers). Minglu Liang is often cited by papers focused on Adipose Tissue and Metabolism (7 papers), Natural product bioactivities and synthesis (5 papers) and Angiogenesis and VEGF in Cancer (5 papers). Minglu Liang collaborates with scholars based in China, United States and Taiwan. Minglu Liang's co-authors include Kai Huang, Wenjing Xu, Cheng Wang, Fengxiao Zhang, Yiqing Li, Shan Deng, Yang Liu, Zhangyin Ming, Aodi He and Xingwen Da and has published in prestigious journals such as Nature Communications, Blood and Diabetes.

In The Last Decade

Minglu Liang

49 papers receiving 878 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Minglu Liang China	20	441	185	128	118	117	52	884
Jie-Jen Lee Taiwan	19	364 0.8×	135 0.7×	115 0.9×	172 1.5×	180 1.5×	34	1.1k
Huifeng Hao China	14	354 0.8×	141 0.8×	58 0.5×	132 1.1×	109 0.9×	35	863
Xiaohu Chen China	14	429 1.0×	136 0.7×	78 0.6×	84 0.7×	63 0.5×	48	808
Qiuling Fan China	21	622 1.4×	194 1.0×	193 1.5×	142 1.2×	53 0.5×	70	1.3k
Jun Hao China	23	629 1.4×	176 1.0×	159 1.2×	174 1.5×	107 0.9×	57	1.3k
Hongxia Yang China	20	450 1.0×	144 0.8×	69 0.5×	211 1.8×	77 0.7×	55	988
Chao Zheng China	21	454 1.0×	130 0.7×	139 1.1×	108 0.9×	151 1.3×	80	1.3k
Xinrui Zhao China	14	436 1.0×	172 0.9×	140 1.1×	78 0.7×	148 1.3×	24	874
Qiang Tang China	17	585 1.3×	229 1.2×	62 0.5×	83 0.7×	195 1.7×	44	1.1k
Qiong‐Yu Mi China	13	441 1.0×	183 1.0×	139 1.1×	254 2.2×	226 1.9×	31	937

Countries citing papers authored by Minglu Liang

Since Specialization

Citations

This map shows the geographic impact of Minglu Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minglu Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minglu Liang more than expected).

Fields of papers citing papers by Minglu Liang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Minglu Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minglu Liang. The network helps show where Minglu Liang may publish in the future.

Co-authorship network of co-authors of Minglu Liang

This figure shows the co-authorship network connecting the top 25 collaborators of Minglu Liang. A scholar is included among the top collaborators of Minglu Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Minglu Liang. Minglu Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Yilong, Minglu Liang, Kaiyuan Liu, et al.. (2025). BAP1 Suppresses White Adipose Tissue Browning and Thermogenesis Through Deubiquitinating KDM1B. Diabetes. 74(7). 1153–1167.

Jiang, Siyu, Dong Yin, Long Chen, et al.. (2025). Erucin Alleviates Cardiac Hypertrophy by Improving Mitochondrial Function via Nrf2‐Sirt3 Pathway. Phytotherapy Research. 39(6). 2989–3001.

Shi, M., et al.. (2025). Isomeranzin activates Gnas-AMPK signaling to drive white adipose browning and curb obesity in mice. EMBO Molecular Medicine. 18(1). 55–90.

Gao, Wenkang, Xiaoli Pan, Weijun Wang, et al.. (2024). Suppression of intestinal Ticam1 ameliorated MASH via Akkermansia muciniphila QAA37749.1 mediated betaine transformation. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1871(1). 167571–167571. 3 indexed citations

Liu, Kaiyuan, et al.. (2024). Myricanol attenuates sepsis-induced inflammatory responses by nuclear factor erythroid 2-related factor 2 signaling and nuclear factor kappa B/mitogen-activated protein kinase pathway via upregulating Sirtuin 1. Inflammopharmacology. 32(3). 1887–1901. 2 indexed citations

Xu, Yating, Di Xia, Kai Huang, & Minglu Liang. (2024). Hypoxia-induced P4HA1 overexpression promotes post-ischemic angiogenesis by enhancing endothelial glycolysis through downregulating FBP1. Journal of Translational Medicine. 22(1). 74–74. 11 indexed citations

Du, Meng, et al.. (2024). Pimpinellin ameliorates macrophage inflammation by promoting RNF146‐mediated PARP1 ubiquitination. Phytotherapy Research. 38(4). 1783–1798. 11 indexed citations

Zhong, Yi, Dandan Huang, Yang Liu, et al.. (2023). LncRNA Nron deficiency protects mice from diet-induced adiposity and hepatic steatosis. Metabolism. 148. 155609–155609. 6 indexed citations

Chen, Can, Luoying Zhang, Jiong Hu, et al.. (2022). β2-adrenergic receptor promotes liver regeneration partially through crosstalk with c-met. Cell Death and Disease. 13(6). 571–571. 9 indexed citations

10.

Hu, Lizhi, Yichen Wu, Long Chen, et al.. (2022). Daidzein suppresses TGF-β1-induced cardiac fibroblast activation via the TGF-β1/SMAD2/3 signaling pathway. European Journal of Pharmacology. 919. 174805–174805. 32 indexed citations

11.

Li, Yue, et al.. (2021). MiR-181b suppresses angiogenesis by directly targeting cellular communication network factor 1. Laboratory Investigation. 101(8). 1026–1035. 9 indexed citations

12.

Zheng, Zhe, Yue Li, Siyuan Fan, et al.. (2021). WW domain-binding protein 2 overexpression prevents diet-induced liver steatosis and insulin resistance through AMPKβ1. Cell Death and Disease. 12(3). 228–228. 10 indexed citations

13.

Du, Meng, Liu Yang, Bing Liu, et al.. (2021). Inhibition of NFAT suppresses foam cell formation and the development of diet‐induced atherosclerosis. The FASEB Journal. 35(10). e21951–e21951. 10 indexed citations

14.

Li, Xiaoguang, et al.. (2020). Apatinib attenuates phenotypic switching of arterial smooth muscle cells in vascular remodelling by targeting the PDGF Receptor‐β. Journal of Cellular and Molecular Medicine. 24(17). 10128–10139. 7 indexed citations

15.

Zhong, Yi, Shaolin He, Kun Huang, & Minglu Liang. (2020). Neferine suppresses vascular endothelial inflammation by inhibiting the NF-κB signaling pathway. Archives of Biochemistry and Biophysics. 696. 108595–108595. 24 indexed citations

16.

Xu, Wenjing, Yuelin Chao, Minglu Liang, Kai Huang, & Cheng Wang. (2020). CTRP13 Mitigates Abdominal Aortic Aneurysm Formation via NAMPT1. Molecular Therapy. 29(1). 324–337. 19 indexed citations

17.

Zhang, Wenyong, Xiao-Fan Hu, Na Wan, et al.. (2019). Protective effect of the glucagon-like peptide-1 analogue liraglutide on carbon tetrachloride-induced acute liver injury in mice. Biochemical and Biophysical Research Communications. 514(2). 386–392. 13 indexed citations

18.

Li, Jia, Jiangtong Peng, Shengnan Zhao, et al.. (2019). Tussilagone Suppresses Angiogenesis by Inhibiting the VEGFR2 Signaling Pathway. Frontiers in Pharmacology. 10. 764–764. 12 indexed citations

19.

Zhao, Shengnan, Minglu Liang, Yilong Wang, et al.. (2018). Chrysin Suppresses Vascular Endothelial Inflammation via Inhibiting the NF-κB Signaling Pathway. Journal of Cardiovascular Pharmacology and Therapeutics. 24(3). 278–287. 23 indexed citations

20.

He, Aodi, Wei Song, Yuanyuan Ma, et al.. (2017). Platelet releasates promote the proliferation of hepatocellular carcinoma cells by suppressing the expression of KLF6. Scientific Reports. 7(1). 3989–3989. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact